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  TITRIMETRIC AND SENSITIVE SPECTRO-
PHOTOMETRIC METHODS FOR THE ASSAY 
OF QUETIAPINE FUMARATE IN 
PHARMACEUTICAL FORMULATIONS 
Quetiapine fumarate (QTF) is a selective monoaminergic antagonist with high 
affinity for the serotonin Type 2 (5HT2), and dopamine type 2 (D2) receptors. 
Titrimetric and spectrophotometric assay of quetiapine fumarate (QTF) using 
perchloric acid and acetic acid as reagents are described. The first method 
(method A) is a non-aqueous titrimetric method and is based on the titration of 
QTF in glacial acetic acid with 0.01 M acetous perchloric acid using crystal vio-
let as indicator. In the second method (method B), QTF has been measured in 
0.1M acetic acid spectrophotometrically at a wavelength of 222 nm. The titri-
metric method was applicable over the range of 2.0–20.0 mg of QTF. The reac-
tion stoichiometry of 1:3 is obtained which served as the basis for calculation. 
In spectrophotometry, Beer’s law was obeyed over the concentration range of 
1.25–15.0 µg mL-1. The linear regression equation of the calibration graph was 
A = 0.0115 + 0.0673c with a regression coefficient (r) of 0.9986 (n = 7). The 
apparent molar absorptivity was calculated to be 4.25×104 L mol-1cm-1 and the 
Sandell sensitivity was 0.0145 µg cm-2. The limits of detection (LOD) and quan-
tification (LOQ) calculated as per the ICH guidelines were 0.07 and 0.21 µg mL-1, 
respectively. Accuracy and precision of the assays were determined by com-
puting the intra-day and inter-day variations at three different levels of QTF. 
The intra-day and inter-day relative standard deviation (%RSD) were in the 
range of 0.99–2.88 and 1.65–2.32%, for method A and B, respectively, with an 
acceptable percentage relative error (%RE) < 2%. The methods were success-
fully applied to the determination of QTF in two different brands of tablets with 
good accuracy and precision and without detectable interference by excipients. 
The methods have demonstrated to be simple and easy to apply in routine 
usage and do not need any costly instrumentation. Therefore, the proposed 
procedures are advantageous and can be adopted in routine quality control 
laboratories in the developing or under developed countries. 
Key words: quetiapine fumarate; assay; non-aqueous titrimetry; UV-spectro-
photometry; pharmaceuticals. 
 
 
Quetiapine fumarate (QTF) is an atypical anti-
psychotic drug [1], synthesized originally by Warawa 
and Migler in 1988 [2] and can be used alone or in 
combination with other medications to treat schizo-
phrenia and bipolar disorder [3,4]. The chemical name 
of QTF is 2-(2-(4-dibenzo[b,f] [1,4]thiazepine-11-yl-1- 
-piperazinyl)ethoxy)ethanol, fumaric acid (1:2 salt) (Fi-
                                                 
Correspondening author: N. Rajendraprasad, Department of 
Studies in Chemistry, Manasagangothri, University of Mysore, 
Mysore 570 006, India. 
E-mail: prasadtnpur@yahoo.co.in 
Paper received: 07 April, 2010 
Paper revised: 20 October, 2010 
Paper accepted: 21 October, 2010 
gure 1) with formula C29H33N3O10S and molecular 
weight of 615.66. 
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Figure 1. Chemical structure of QTF. 
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Many methods have been used to determine QTF 
in biological samples or matrices and these include 
HPLC with UV [5-11], chemiluminescence [12], elec-
trospray ionization MS [13-16], tandem MS/MS de-
tection [17-18], UPLC with tandem MS detection 
[19,20], GC [21] and voltammetry [22]. QTF is not offi-
cial in any pharmacopoeia. Methods based on diffe-
rent techniques such as polarography [23], capillary 
zone electrophoresis [24,25], HPTLC [26,27], HPLC 
[28-30] and UV spectrophotometry [24,31] have ear-
lier been employed for the determination of QTF in 
pharmaceutical formulations.  
There is no titrimetric method reported for the 
determination of QTF in pharmaceuticals. Pucci et al. 
[24] have reported a spectrophotometric method for 
the determination of QTF after converting the drug 
into its free base by using 50 mM phosphate buffer 
(pH 2.5) as solvent. The assay was carried out by 
measuring the absorbance of quetiapine free base at 
a wavelength of 246 nm. The linearity was observed 
in the range of 5-25 µg mL-1 QTF. The UV spectro-
photometric method developed by Fursule et al. [31] 
involved the measurement of QTF at 290 nm in water 
and Beer’s law was obeyed in the range 6-54 µg mL-1. 
The reported spectrophotometric methods have some 
disadvantages such as usage of organic toxic solvent 
such as methanol or buffer [24] and less sensitivity 
[31]. In the present paper, micro-titrimetric and sensi-
tive spectrophotometric procedures are described for 
the assay of QTF in pharmaceuticals. 
EXPERIMENTAL 
Apparatus 
Perkin-Elmer Lambda-35 UV-Vis double beam 
spectrophotometer, Elico UV/Vis Sl-164 spectropho-
tometer, Shimadzu Pharmaspec 1700 UV/Vis spec-
trophotometer and Systronic UV-Vis spectrophotome-
ter 2201, all with 1 cm matched cells were used for 
absorbance measurements. Two Borosil and two Qua-
ligens burettes were used for titration. Chromatogra-
phic analysis was carried out using an Alliance Wa-
ters HPLC system equipped with Alliances 2657 se-
ries low pressure quaternary pump, a programmable 
variable wavelength UV-Vis detector, Waters 2996 
photodiode array detector and auto sampler. Data 
were collected and processed using Waters Empower 
2.0 software. 
Materials 
All chemicals used were of analytical reagent 
grade. QTF pure drug was kindly provided by Cipla 
Ltd, Bangalore, India, as a gift and used as received. 
Qutipin-200 (Batch No. AD82847; EXP 1/12/2011) 
and Qutipin-100 (Batch No. AD90376; EXP 1/1/2012) 
tablets-manufactured from Sun Pharmaceuticals Ltd, 
Mumbai, India, were purchased from local market.  
Reagents and solutions 
All solutions were made in glacial acetic acid (S. 
D. Fine Chem, Mumbai, India) in method A unless 
mentioned otherwise. 
Perchloric acid (0.01 M). A stock solution of 0.1 
M perchloric acid was purchased from Merck, Mum-
bai, India, and it was diluted appropriately with glacial 
acetic acid to get a working concentration of 0.01 M 
and standardized with pure potassium hydrogen 
phthalate (S. D. Fine Chem, Mumbai, India) [32]. 
Crystal violet indicator (0.1%). Prepared by dis-
solving 50 mg of dye (S. D. Fine Chem, Mumbai, 
India) in 50 mL of glacial acetic acid. 
Acetic acid (CH3COOH) (0.1 M). Appropriate vo-
lume of glacial acetic acid was diluted with distilled 
water to get 0.1 M CH3COOH for use in spectropho-
tometry. 
Standard drug solution 
A stock standard solution containing 2 mg mL-1 
QTF was prepared in glacial acetic acid and used in 
titrimetry (method A). A stock standard solution equi-
valent to 250 µg mL-1 QTF was prepared by dissol-
ving accurately weighed 25 mg of pure drug in 100 
mL of 0.1M CH3COOH. This solution was further di-
luted with the same solvent to get working concen-
tration of 50 µg mL-1 for use in spectrophotometric 
work (method B). 
General analytical procedures 
Method A. An aliquot of the pure drug solution 
equivalent to 2.0-20.0 mg of QTF was measured ac-
curately and transferred into a clean and dry 100 mL 
titration flask and the solution was diluted to 25 mL by 
adding glacial acetic acid. Two drops of crystal violet 
indicator were added and titrated with standard 0.01 
M perchloric acid to a blue colour end point. The 
amount of the drug in the measured aliquot was cal-
culated from:  
Amount (mg) = VMwR/3 
where V – volume of perchloric acid required, mL; Mw –  
– relative molecular mass of the drug (615.66); and R –  
– molarity of the perchloric acid, obtained from stan-
dardization with potassium hydrogen phthalate (100% 
pure, primary standard) where the stoichiometric re-
lationship between HClO4 and PHP is 1:1. 
Method B, calibration curve. Into a series of 10 
mL calibration flasks, aliquots of QTF standard solu-
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tion (50 µg mL-1) equivalent to 1.25-15.0 µg mL-1 QTF 
were accurately transferred and the volume made up 
to mark with 0.1M CH3COOH. The absorbance of 
each solution was measured at 222 nm vs 0.1 M 
CH3COOH.  
The calibration curve was plotted and the con-
centration of the unknown was read from the calibra-
tion graph or computed from the regression equation 
derived using Beer’s law data. 
Procedure for analysing QTF tablets 
Method A. Twenty tablets from each brand 
(Qutipin-200 or Qutipin-100) were weighed separately 
and ground into a fine powder. An amount of powder 
equivalent to 200 mg of QTF was weighed accurately 
and transferred into a 100 mL calibrated flask, 70 mL 
of glacial acetic acid was added and shaken for about 
20 min followed by warming for 10 min. Then the vo-
lume was made up to the mark with glacial acetic 
acid, mixed well and filtered using Whatman No. 42 
filter paper. The first 10 mL portion of the filtrate was 
discarded. A suitable aliquot was next subjected to 
analysis following the procedure as described earlier. 
Method B. An amount of powdered tablet equi-
valent to 25 mg of QTF from Qutipin-200 or Qutipin- 
-100 was weighed and transferred into a 100 mL volu-
metric flask. The content was shaken well with about 
70 mL of 0.1 M CH3COOH for 20 min. The mixture 
was diluted to the mark with the same acid. It was fil-
tered using Whatman No. 42 filter paper. The first 10 
mL portion of the filtrate was discarded and a subse-
quent portion was diluted to get a working concen-
tration of 50 µg mL-1 and subjected to analysis by 
spectrophotometry as described for pure drug. 
Reference HPLC method 
A quantity of tablet powder containing 25 mg 
QTF was dissolved ultrasonically and diluted to 50 mL 
with methanol. The solution was filtered through a 
0.45 μm filter membrane and a 1 mL portion of the fil-
trate was diluted to 10 mL with methanol. A 10 µL por-
tion of above solution was injected and analysed on a 
5 μm Hypersil ODS-C18 column (25 cm×4.6 mm i.d.), 
with methanol/0.5% triethylamine (39:11, pH 7-8) as 
mobile phase at a flow rate of 1 mL/min and UV de-
tection was made at 254 nm. Figure 2 is a typical 
chromatogram obtained for QTF under the described 
chromatographic conditions. 
Recovery study 
Method A. Three different amounts of pure drug 
solution equivalent to 4.0, 8.0 and 12.0 mg QTF were 
spiked into QTF tablet solution containing 7.95 mg 
(Qutipin-200) or 8.25 mg (Qutipin-100), mixed well 
and the resulted solution was subjected to analysis by 
following the general titrimetric procedure.  
Method B. Different aliquots of pure drug solu-
tion equivalent to 2.0, 4.0 and 6.0 µg mL-1 QTF were 
spiked separately into tablet solutions containing 3.91 
and 4.10 µg mL-1 QTF from Qutipin-200 and Qutipin- 
-100, respectively, and then the analysis was perfor-
med as described in the procedure for calibration cur-
ve. 
Figure 2. A typical chromatogram obtained for 50 µg mL-1 QTF (Rt = 3.48 min) under 
the experimental conditions described in reference method. 
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Validation 
Intra-day and inter-day accuracy and precision. 
Three different amounts/concentrations of QTF within 
the range of study in each method (6.0, 12.0 and 18.0 
mg, method A, and 4.0, 8.0 and 12.0 µg mL-1, method 
B) were analyzed in seven replicates during the same 
day (intra-day precision) and five consecutive days 
(inter-day precision) by following general analytical 
procedures. For inter-day precision, each day anal-
ysis was performed in triplicate and pooled-standard 
deviation was calculated by using the following for-
mula [33]: 
2 2 2
1 2 3
p
( ) ( ) ( )i j kX X X X X XS
N k
− + − + −
=
−  
where Xi, Xj and Xk are individual amount/concen-
tration of QTF found in each set; X1, X2 and X3 are the 
mean values found for the data sets 1, 2 and 3, res-
pectively, and N is the total number of measurements 
from k sets. 
The accuracy was evaluated as percentage re-
lative error (%RE) between the found and taken 
amounts/concentrations using the relationship: 
T F
T
( )
% 100
QTF QTF
RE
QTF
−
= ×  
where the subscripts T and F refer to taken and found, 
respectively. 
Determination of limits of detection (LOD) and 
quantification (LOQ)  
A replicate measurement of the absorbance of 
0.1 M CH3COOH at 222 nm was made (n = 5) and the 
standard deviation value was evaluated. The limits of 
detection (LOD) and quantification (LOQ) are calcu-
lated according to ICH guidelines [34] using the for-
mulae:  
LOD = 3.3S/b and LOQ = 10S/b 
where S is the standard deviation obtained from ab-
sorbance values measured for 0.1 M CH3COOH, and 
b is the slope of the calibration plot. 
Ruggedness 
A triplicate analysis was performed by four diffe-
rent analysts, using four different burettes (method A) 
and four different spectrophotometers (method B) for 
three different amounts (6.0, 12.0 and 18.0 mg, me-
thod A) or concentrations (4.0, 8.0 and 12.0 µg mL-1, 
method B) of QTF. The amount/concentration of QTF 
found in each case was calculated. The inter-mediate 
precision expressed as RSD was evaluated. 
THEORY 
Method A 
The method is based on the principle that sub-
stances which are weakly basic in aqueous medium 
exhibit enhanced basicity in non-aqueous media thus 
allowing their easy determination. Acetic acid displays 
acidic properties in dissociating to produce protons 
[35]: 
CH3COOH CH3COO-   +   H+  
But in the presence of perchloric acid, a far 
stronger acid, it will accept a proton: 
CH3COOH  +  HClO4 CH3COOH2+ +  ClO4-  
2CH3COOH2+   +   2CH3COO- 4CH3COOH  
Since the CH3COOH2
+ readily donates its proton 
to a base, a solution of perchloric acid in glacial acetic 
acid functions as a strongly acidic solution. When a 
weak base, such as QTF, is dissolved in acetic acid, 
the acetic acid exerts its levelling effect and enhances 
the basic property of the QTF. It is possible, therefore, 
to titrate a solution of QTF in acetic acid with per-
chloric acid. The titration results revealed that a reac-
tion stoichiometry of 1:3 (drug:titrant) was obtained 
which served as the basis for calculation. Using 0.01 
M perchloric acid, 2.0-20.0 mg of QTF was conve-
niently determined. The relationship between the drug 
amount and the titration end point was examined. The 
linearity between two parameters is apparent from the 
correlation coefficient of 0.9985 obtained by the me-
thod of least squares. From this it is implied that the 
reaction between QTF and perchloric acid proceeds 
stoichiometrically in the ratio 1:3 in the range studied. 
The possible neutralization reaction is postulated in 
Scheme 1. 
Method B 
Spectral characteristics. A solution of QTF in 0.1 
M CH3COOH exhibited an absorption maximum at 
222 nm. At this wavelength the corresponding blank 
solution had insignificant absorbance as shown by the 
absorption spectra in Figure 3. 
RESULTS AND DISCUSSION 
Validation of the proposed analytical procedures 
Conformity to Beer’s law (method B). Beer’s law 
was obeyed for the concentration range of 1.25–15 
µg mL-1 of the drug in 0.1 M CH3COOH. The calibra-
tion graph was described by the regression equation: 
y = a + bx 
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Figure 3. Absorption spectra of QTF (10 µg mL-1) in 
0.1 M CH3COOH (A) and 0.1 M CH3COOH (a). 
where y – absorbance of 1-cm layer of solution; a – 
– intercept; b – slope; x – concentration in µg mL-1). Re-
gression analysis of the Beer’s law data using the 
method of least squares was made to evaluate the 
slope (b), intercept (a) and correlation coefficient (r) 
for each system. A log–log plot of absorbance vs. con-
centration yielded a straight line with a slope equal to 
0.9804, further establishing the linear relation bet-
ween the two variables. The optical characteristics 
such as molar absorptivity and Sandell sensitivity (li-
mit of determination as the weight in µg per mL of so-
lution, which corresponds to an absorbance of A = 
= 0.001 measured in a cuvette of cross-sectional area 
1 cm2 and l = 1 cm path length) values [36] are re-
corded and found to be 4.25×104 L mol-1 cm-1 and 
0.0145 µg cm-2, respectively. The limits of detection 
(LOD) and quantitation (LOQ) are calculated to be 
0.07 and 0.21 µg mL-1, respectively. The high value of 
ε and low value of Sandell sensitivity and LOD indi-
cate the high sensitivity of the proposed method. 
Intra-day and inter-day accuracy and precision 
The repeatability of the proposed methods was 
determined by performing replicate measurements for 
three different amounts/concentrations of QTF. The 
results of this study are compiled in Table 1 and speak 
of the excellent intermediate precision (RSD < 3%) 
and accuracy (RE < 2%) of the results. 
Ruggedness of the methods 
The ruggedness of the methods was evaluated 
on the basis of intermediate precision expressed as 
RSD. The inter-analysts RSD values were in the ran-
ge from 0.99 to 2.01% whereas the inter-instruments 
RSD for the same QTF amounts/concentrations were 
1.89–2.50% suggesting that the developed methods 
are rugged. 
Analysis of pharmaceutical formulations 
The proposed methods were applied for the 
quantification of QTF in commercial tablets. The re-
sults were compared with those obtained using a re-
Table. 1. Intra-day and inter-day accuracy and precision (RE - relative error; RSD - relative standard deviation) 
Method A Method B 
Amount of 
QTF taken 
mg 
Intra-day accuracy 
and precision 
Inter-day accuracy 
and precision Concentration 
of QTF taken
µg mL-1 
Intra-day accuracy 
and precision 
Inter-day accuracy 
and precision 
QTF 
found, mg 
%RE %RSD 
QTF found, 
mg 
%RE %RSD
QTF found
µg mL-1 
%RE %RSD 
QTF found 
µg mL-1 
%RE %RSD
6.0 
12.0 
18.0 
6.08 
12.11 
18.12 
1.33 
0.92 
0.67 
1.23 
0.99 
1.02 
6.10 
12.13 
18.10 
1.67
1.08
0.56
2.69 
2.88 
1.99 
4.0 
8.0 
12.0 
3.93 
7.95 
12.03 
1.75 
0.63 
0.25 
2.12 
1.65 
1.56 
4.06 
8.09 
12.11 
1.50 
1.13 
0.92 
1.98 
2.13 
2.32 
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QTF 3H+
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+ 3ClO4 QTF 3H+. 3ClO4QTF 3H+  
Scheme 1. Possible neutralization reaction between QTF and perchloric acid in glacial acetic acid medium. 
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ference method [30]. The reference method is a liquid 
chromatography where QTF has been detected using 
UV detector at 254 nm. The assay was performed for 
two different brands as described in the chromatogra-
phic procedure and the percentage recovery of QTF 
was evaluated and it was found to be in the range 
97.8–103.1. The statistical comparison of the results 
revealed (Table 2) no any significant difference be-
tween the performance of the proposed methods and 
reference method with respect to accuracy and preci-
sion as revealed by the Student’s t-value and vari-
ance ratio F-value [37]. 
Recovery study 
The accuracy of the proposed methods was 
further ascertained by performing recovery experi-
ments by standard addition method. The recovery 
was assessed by determining the agreement between 
the measured standard concentration and added known 
concentration to the sample. The percentage reco-
very values obtained from three replicate measure-
ments at each level of drug were in the range from 
97.25 to 103.1 with relative standard deviation in the 
range 0.62–1.46. Closeness of the results to 100% 
showed good accuracy of the methods. The results 
are shown in Table 3. 
CONCLUSIONS 
One titrimetric and one spectrophotometric me-
thod were developed for the determination of queti-
apine fumarate and the methods were validated as 
per the current ICH guidelines. The proposed me-
thods have distinct advantages over the existing me-
thods in terms of simplicity of technique and ease of 
performance and do not need expensive and highly 
sophisticated equipment or high-cost organic solvents 
which are required for HPLC. In particular, the titri-
metry is much simpler in technique, more rapid than 
all the methods reported so far for QTF. It is appli-
cable over a semi-micro range (2-20 mg), requires in-
expensive chemicals, yet provides very accurate and 
precise results. The proposed spectrophotometric 
method is more sensitive (ε = 4.25×104 L mol-1 cm-1) 
than the reported methods [24,31] and fairly accurate 
and precise. Hence, the methods can be used in rou-
tine analysis in pharmaceutical quality control labora-
tories. 
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Table 2. Results of analysis of tablets by the proposed methods and statistical comparison of the results with the reference method 
Tablet brand name Nominal amount, mg/tablet 
Founda (percent of label claim±SD) 
Reference method 
Proposed methods 
Method A Method B 
Qutipin-200 200 98.56±1.26 99.42±1.74 
t = 0.91 
F = 1.91 
97.8±0.76 
t = 1.19 
F = 2.75 
Qutipin-100 100 101.4±1.52 103.1±2.04 
t = 1.51 
F = 1.80 
102.6±0.94 
t = 1.54 
F = 2.61 
a
Mean value of 5 determinations; tabulated t-value at the 95 % confidence level and for four degrees of freedom is 2.77; tabulated F-value at the 95 % 
confidence level and for four degrees of freedom is 6.39 
Table 3. Results of recovery study via standard-addition method 
Tablets 
studied 
Titrimetry Spectrophotometry 
QTF in 
tablet, mg 
Pure QTF 
added, mg
Total found 
mg 
Pure QTF re-
covered±SDa, %
QTF in tablet
µg mL-1 
Pure QTF added
µg mL-1 
Total found 
µg mL-1 
Pure QTF re-
covered±SDa, % 
Qutipin-200 7.95 
7.95 
7.95 
4.0 
8.0 
12.0 
12.00 
15.93 
20.06 
101.3±0.62 
99.75±0.85 
100.9±0.62 
3.91 
3.91 
3.91 
2.0 
4.0 
6.0 
5.86 
7.90 
9.93 
97.32±0.86 
99.64±1.04 
100.3±0.92 
Qutipin-100 8.25 
8.25 
8.25 
4.0 
8.0 
12.0 
12.14 
16.36 
20.35 
97.25±1.46 
101.4±0.82 
100.8±1.14 
4.10 
4.10 
4.10 
2.0 
4.0 
6.0 
6.16 
8.12 
10.18 
103.1±0.62 
100.6±0.74 
101.3±0.87 
aMean value of three determinations 
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NAUČNI RAD 
  VOLUMETRIJSKA I OSETLJIVA SPEKTROFOTO-
METRIJSKA METODA ZA ODREĐIVANJE 
KUETIAPIN FUMARATA U FARMACEUTSKIM 
PREPARATIMA 
Kuetiapin fumarat (KTF) je selektivni monoaminoergični antagonist sa visokim afinitetom 
prema receptorima serotoninu Tip 2 (5HT2), i dopaminu tip 2 (D2). U radu su opisana 
volumetrijsko i spektrofotometrijsko određivanje kuetiapin fumarata (KTF) koristeći per-
hlornu i sirćetnu kiselinu, kao reagense. Prvi metod (metoda A) je nevodena volume-
rijska metoda i zasniva se na titraciji KTF u glacijalnoj sirćetnoj kiselini sa 0,01 M per-
hlornom kiselinom koristeći kristal violet kao indikator. U drugoj metodi (metoda B), KTF 
je određivan u 0,1 M sirćetnoj kiselini spektrofotometrijski na talasnoj dužini od 222 nm. 
Volumetrijska metoda je primenjiva u  opsegu od 2,0-20,0 mg KTF. Stehiometrijiski od-
nos od 1:3 je poslužio kao osnova za dalje računanje. U spektrofotometriji, Beer-ov za-
kon je važio u opsegu koncentracija od 1,25-15,0 mg ml-1. Linearna regresija jednačine 
kalibracione krive je A = 0,0115 + 0,0673c sa koeficijentom regresije 0.9986 (n = 7). 
Prividna molarna apsorpcija je određena i iznosi 4,25×104 L mol-1cm-1, a Sandell-ova  
osetljivost je 0,0145 mg cm-2. Granice detekcije (LOD) i kvantifikaciju (LOK) su računate 
po ICH upustvu i iznose 0,07 i 0,21 mg ml-1, respektivno. Tačnost i preciznost testova 
određene su korišćenjem dnevnih i višednevnih varijacija na tri različita nivoa KTF. Re-
lativne standardne devijacije dnevnih i višednevnih varijacija bile su u opsegu od 0,99–
–2,88 i 1,65–2,32% za metode A i B, respektivno, uz prihvatljivu relativnu grešku (<2 %). 
Metode su uspešno primenjene u određivanju KTF u dve različite vrste tableta sa dob-
rom tačnošću i preciznošću. Metode su se pokazale jednostavnim i lakim za primenu u 
svakodnevnoj upotrebi bez korišćenja skupih instrumenata. Ove procedure imaju pred-
nosti i mogu biti usvojene u laboratorijama za rutinsku kontrolu kvaliteta u zemljama u 
razvoju ili nerazvijenim zemljama. 
Ključne reči: kuetiapin fumarat; test; nevodena titracija; UV spektrofotometrija; 
farmaceutski. 
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